NM_173595.4(ANKRD52):c.2656G>A (p.Ala886Thr) AND not specified
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Feb 2, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004422246.1
Allele description [Variation Report for NM_173595.4(ANKRD52):c.2656G>A (p.Ala886Thr)]
NM_173595.4(ANKRD52):c.2656G>A (p.Ala886Thr)
Condition(s)
- Synonyms:
- AllHighlyPenetrant
- Identifiers:
- MedGen: CN169374
-
Mus musculus epoxide hydrolase 3 (Ephx3), transcript variant 2, mRNA
Mus musculus epoxide hydrolase 3 (Ephx3), transcript variant 2, mRNAgi|1371542752|ref|NM_001347341.2|Nucleotide
-
beta-1,3-glucanosyltransferase [Neurospora crassa OR74A]
beta-1,3-glucanosyltransferase [Neurospora crassa OR74A]gi|85090980|ref|XP_958678.1|Protein
-
Nasua nasua
Nasua nasuaNasua nasua RefSeq GenomeBioProject
-
Endocrine Disease - 2021 Guidelines
Endocrine Disease - 2021 Guidelines
-
ND2 [Blattella bisignata]
ND2 [Blattella bisignata]Gene ID:13540162Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 7, 2024